

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.40594708 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.40594708 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.59229592 |
| 4 | fatty acid elongation (GO:0030497) | 6.49443428 |
| 5 | presynaptic membrane assembly (GO:0097105) | 6.12761158 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.64954912 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.64161979 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.64161979 |
| 9 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.53214374 |
| 10 | presynaptic membrane organization (GO:0097090) | 5.49378734 |
| 11 | short-term memory (GO:0007614) | 5.41024087 |
| 12 | positive regulation of protein kinase C signaling (GO:0090037) | 5.40862859 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.33100493 |
| 14 | glycogen catabolic process (GO:0005980) | 5.28164490 |
| 15 | glucan catabolic process (GO:0009251) | 5.02684592 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.98942905 |
| 17 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 4.93385266 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.82036543 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.81543692 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.81543692 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.81543692 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.81543692 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.81543692 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.81543692 |
| 25 | limb bud formation (GO:0060174) | 4.66014954 |
| 26 | cellular polysaccharide catabolic process (GO:0044247) | 4.58326582 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.58161299 |
| 28 | polysaccharide catabolic process (GO:0000272) | 4.51075279 |
| 29 | postsynaptic membrane organization (GO:0001941) | 4.50336194 |
| 30 | detection of other organism (GO:0098543) | 4.45432023 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32498603 |
| 32 | negative thymic T cell selection (GO:0045060) | 4.31358061 |
| 33 | negative T cell selection (GO:0043383) | 4.30565590 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 4.28154971 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 4.26912148 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 4.22834903 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 4.21910486 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 4.15345746 |
| 39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14878073 |
| 40 | cellular extravasation (GO:0045123) | 4.14491757 |
| 41 | oligodendrocyte differentiation (GO:0048709) | 4.08742149 |
| 42 | detection of bacterium (GO:0016045) | 4.05884328 |
| 43 | positive T cell selection (GO:0043368) | 4.02988262 |
| 44 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.98599319 |
| 45 | positive thymic T cell selection (GO:0045059) | 3.98338262 |
| 46 | microglial cell activation (GO:0001774) | 3.96741521 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.95578899 |
| 48 | detection of external biotic stimulus (GO:0098581) | 3.94326943 |
| 49 | axon ensheathment (GO:0008366) | 3.93474090 |
| 50 | ensheathment of neurons (GO:0007272) | 3.93474090 |
| 51 | myelination (GO:0042552) | 3.90792836 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.84747891 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.83422120 |
| 54 | response to peptidoglycan (GO:0032494) | 3.78857376 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 3.77725762 |
| 56 | histone H3-K36 demethylation (GO:0070544) | 3.77447794 |
| 57 | T cell selection (GO:0045058) | 3.74884739 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.74390009 |
| 59 | retina layer formation (GO:0010842) | 3.71698136 |
| 60 | centriole replication (GO:0007099) | 3.70973885 |
| 61 | positive regulation of granulocyte differentiation (GO:0030854) | 3.67807933 |
| 62 | leukocyte aggregation (GO:0070486) | 3.66368486 |
| 63 | activated T cell proliferation (GO:0050798) | 3.61814784 |
| 64 | metanephric nephron tubule development (GO:0072234) | 3.61611895 |
| 65 | metanephric tubule development (GO:0072170) | 3.61611895 |
| 66 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.60921035 |
| 67 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58925481 |
| 68 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.55565389 |
| 69 | lymphoid progenitor cell differentiation (GO:0002320) | 3.54208041 |
| 70 | tongue development (GO:0043586) | 3.53645935 |
| 71 | detection of biotic stimulus (GO:0009595) | 3.52266194 |
| 72 | regulation of pigment cell differentiation (GO:0050932) | 3.50306985 |
| 73 | macrophage activation (GO:0042116) | 3.48647572 |
| 74 | hepatocyte apoptotic process (GO:0097284) | 3.48114657 |
| 75 | response to folic acid (GO:0051593) | 3.48068072 |
| 76 | nephron epithelium development (GO:0072009) | 3.46770425 |
| 77 | melanin metabolic process (GO:0006582) | 3.45074591 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.44789955 |
| 79 | negative regulation of myotube differentiation (GO:0010832) | 3.42756408 |
| 80 | response to interleukin-15 (GO:0070672) | 3.42735245 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 3.41409844 |
| 82 | organ growth (GO:0035265) | 3.40434020 |
| 83 | neutrophil activation (GO:0042119) | 3.37320896 |
| 84 | T cell migration (GO:0072678) | 3.35573360 |
| 85 | neuron cell-cell adhesion (GO:0007158) | 3.35103626 |
| 86 | melanin biosynthetic process (GO:0042438) | 3.33642602 |
| 87 | response to host immune response (GO:0052572) | 3.33259803 |
| 88 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33259803 |
| 89 | response to muramyl dipeptide (GO:0032495) | 3.33123254 |
| 90 | negative regulation of protein localization to cell surface (GO:2000009) | 3.31130568 |
| 91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30623288 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30163653 |
| 93 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.30058294 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29912445 |
| 95 | myeloid cell activation involved in immune response (GO:0002275) | 3.29022782 |
| 96 | thymic T cell selection (GO:0045061) | 3.27413202 |
| 97 | positive regulation of glycogen metabolic process (GO:0070875) | 3.25166089 |
| 98 | GMP metabolic process (GO:0046037) | 3.25165575 |
| 99 | metanephric nephron epithelium development (GO:0072243) | 3.23213196 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.21290145 |
| 101 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21000134 |
| 102 | tolerance induction (GO:0002507) | 3.20709357 |
| 103 | eye photoreceptor cell differentiation (GO:0001754) | 3.17743607 |
| 104 | photoreceptor cell differentiation (GO:0046530) | 3.17743607 |
| 105 | cellular carbohydrate catabolic process (GO:0044275) | 3.17168001 |
| 106 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15976288 |
| 107 | interferon-gamma production (GO:0032609) | 3.15141948 |
| 108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.13996828 |
| 109 | response to host (GO:0075136) | 3.12624439 |
| 110 | response to host defenses (GO:0052200) | 3.12624439 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12624439 |
| 112 | immunoglobulin mediated immune response (GO:0016064) | 3.11723605 |
| 113 | regulation of tolerance induction (GO:0002643) | 3.11244301 |
| 114 | endothelium development (GO:0003158) | 3.09926163 |
| 115 | myeloid leukocyte mediated immunity (GO:0002444) | 3.08520053 |
| 116 | facial nerve structural organization (GO:0021612) | 3.07831144 |
| 117 | mesonephros development (GO:0001823) | 3.06496671 |
| 118 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.06429056 |
| 119 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.05504545 |
| 120 | positive regulation of mast cell activation (GO:0033005) | 3.05151092 |
| 121 | regulation of T cell tolerance induction (GO:0002664) | 3.05080269 |
| 122 | cellular response to interleukin-15 (GO:0071350) | 3.03750821 |
| 123 | metanephric epithelium development (GO:0072207) | 3.03441827 |
| 124 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02564240 |
| 125 | developmental pigmentation (GO:0048066) | 3.00373120 |
| 126 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.99734288 |
| 127 | granulocyte activation (GO:0036230) | 2.99699220 |
| 128 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.99001379 |
| 129 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.98552460 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.98552460 |
| 131 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98445130 |
| 132 | defense response to protozoan (GO:0042832) | 2.95904356 |
| 133 | positive regulation of interferon-alpha production (GO:0032727) | 2.95653276 |
| 134 | regulation of regulatory T cell differentiation (GO:0045589) | 2.94171765 |
| 135 | negative regulation of adaptive immune response (GO:0002820) | 2.94050902 |
| 136 | nephron tubule development (GO:0072080) | 2.93950411 |
| 137 | GPI anchor biosynthetic process (GO:0006506) | 2.93330228 |
| 138 | respiratory burst (GO:0045730) | 2.92880144 |
| 139 | positive regulation of calcium ion import (GO:0090280) | 2.92106111 |
| 140 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.91458876 |
| 141 | neuron remodeling (GO:0016322) | 2.91028375 |
| 142 | secondary metabolite biosynthetic process (GO:0044550) | 2.90767082 |
| 143 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.90261057 |
| 144 | hemidesmosome assembly (GO:0031581) | 2.90113483 |
| 145 | dendritic cell migration (GO:0036336) | 2.90044294 |
| 146 | negative regulation of B cell proliferation (GO:0030889) | 2.89651315 |
| 147 | very long-chain fatty acid metabolic process (GO:0000038) | 2.88557719 |
| 148 | regulation of mast cell degranulation (GO:0043304) | 2.88386568 |
| 149 | cranial nerve morphogenesis (GO:0021602) | 2.88239146 |
| 150 | protein heterotetramerization (GO:0051290) | 2.88174694 |
| 151 | UV protection (GO:0009650) | 2.83493212 |
| 152 | enteric nervous system development (GO:0048484) | 2.81487206 |
| 153 | regulation of mast cell activation (GO:0033003) | 2.80455894 |
| 154 | membrane assembly (GO:0071709) | 2.79215050 |
| 155 | cranial nerve structural organization (GO:0021604) | 2.78728259 |
| 156 | regulation of somitogenesis (GO:0014807) | 2.77366068 |
| 157 | B cell homeostasis (GO:0001782) | 2.74278374 |
| 158 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73703090 |
| 159 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.73460299 |
| 160 | myelin maintenance (GO:0043217) | 2.73181244 |
| 161 | GPI anchor metabolic process (GO:0006505) | 2.72886475 |
| 162 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.72270112 |
| 163 | regulation of interferon-alpha production (GO:0032647) | 2.72095108 |
| 164 | regulation of timing of cell differentiation (GO:0048505) | 2.71538569 |
| 165 | ribosomal small subunit biogenesis (GO:0042274) | 2.70712841 |
| 166 | glycogen biosynthetic process (GO:0005978) | 2.68927422 |
| 167 | glucan biosynthetic process (GO:0009250) | 2.68927422 |
| 168 | response to methylmercury (GO:0051597) | 2.68366445 |
| 169 | regulation of granulocyte differentiation (GO:0030852) | 2.67390055 |
| 170 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.67020237 |
| 171 | positive regulation of tolerance induction (GO:0002645) | 2.67017375 |
| 172 | regulation of protein kinase C signaling (GO:0090036) | 2.66652694 |
| 173 | mRNA modification (GO:0016556) | 2.66596480 |
| 174 | regulation of protein kinase A signaling (GO:0010738) | 2.65768390 |
| 175 | import into cell (GO:0098657) | 2.64022462 |
| 176 | androgen biosynthetic process (GO:0006702) | 2.63883020 |
| 177 | sympathetic nervous system development (GO:0048485) | 2.62166918 |
| 178 | omega-hydroxylase P450 pathway (GO:0097267) | 2.61978450 |
| 179 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.58952142 |
| 180 | neuronal action potential propagation (GO:0019227) | 2.58372043 |
| 181 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.57823523 |
| 182 | oligosaccharide catabolic process (GO:0009313) | 2.57198744 |
| 183 | polyol transport (GO:0015791) | 2.55676316 |
| 184 | cranial nerve development (GO:0021545) | 2.54740479 |
| 185 | renal tubule development (GO:0061326) | 2.51634801 |
| 186 | glial cell differentiation (GO:0010001) | 2.51321928 |
| 187 | centriole assembly (GO:0098534) | 2.51078329 |
| 188 | positive regulation of protein tyrosine kinase activity (GO:0061098) | 2.50451754 |
| 189 | cholesterol biosynthetic process (GO:0006695) | 2.50300722 |
| 190 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50243940 |
| 191 | neutrophil mediated immunity (GO:0002446) | 2.49648153 |
| 192 | otic vesicle formation (GO:0030916) | 2.47793407 |
| 193 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.46713242 |
| 194 | mannosylation (GO:0097502) | 2.45484944 |
| 195 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.44840838 |
| 196 | negative regulation of interleukin-10 production (GO:0032693) | 2.43099472 |
| 197 | branch elongation of an epithelium (GO:0060602) | 2.42292888 |
| 198 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.41196431 |
| 199 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.41196431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.07360283 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.01468996 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.51764067 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.87393814 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.00333555 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.46286692 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.37425537 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.36841867 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34954781 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18009581 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06189128 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.04032065 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.95427086 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.87731228 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.81485966 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.81212701 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.80489660 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77961592 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.73829643 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.65947369 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.60690729 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56314706 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.55689409 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.48539584 |
| 25 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46590267 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.43260320 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.37871303 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.35118292 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34401817 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.33991973 |
| 31 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.31321450 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.30097562 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.29633477 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28744085 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 2.28217145 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.27995654 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.27945722 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.27945722 |
| 39 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.26142383 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18908190 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17334042 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16919519 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.13464908 |
| 44 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13130603 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12779920 |
| 46 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.10939380 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.10051204 |
| 48 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.08397436 |
| 49 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.08124185 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.06943864 |
| 51 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.04591935 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 2.02688931 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.02506556 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99467029 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.95035130 |
| 56 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93672575 |
| 57 | * MAF_26560356_Chip-Seq_TH1_Human | 1.93468490 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92614897 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91980334 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91558227 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.89447458 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89406963 |
| 63 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.86815665 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.76611688 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.74928408 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72813223 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.72614647 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72149305 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.67722468 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67216476 |
| 71 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64601499 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64196235 |
| 73 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.63880277 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63109562 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.62447226 |
| 76 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62167991 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60263321 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59048146 |
| 79 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.58547353 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58507604 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58334585 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58017267 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.56511507 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.56176123 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56096942 |
| 86 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53223067 |
| 87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51821308 |
| 88 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.51513877 |
| 89 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50462178 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.47776697 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44655128 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44633976 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40311222 |
| 94 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37103334 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35968515 |
| 96 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.34463439 |
| 97 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.33086475 |
| 98 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32935717 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.32564051 |
| 100 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32406977 |
| 101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30866988 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30644602 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29379150 |
| 104 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.29154697 |
| 105 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29020017 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28850183 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28049635 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26394545 |
| 109 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.24952130 |
| 110 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.24572638 |
| 111 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22288965 |
| 112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21804895 |
| 113 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21129797 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21093619 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17696726 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15381083 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.15034983 |
| 118 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14877084 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13868234 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13634590 |
| 121 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11827909 |
| 122 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11759291 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11672065 |
| 124 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11646598 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09728880 |
| 126 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.08790546 |
| 127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.08480005 |
| 128 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08260600 |
| 129 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07666332 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07659987 |
| 131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06552611 |
| 132 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06268383 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05304381 |
| 134 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04947868 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04795374 |
| 136 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04597940 |
| 137 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04204851 |
| 138 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04091676 |
| 139 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04034567 |
| 140 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03863125 |
| 141 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.02981874 |
| 142 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02720279 |
| 143 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02245254 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01704557 |
| 145 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01619274 |
| 146 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00921481 |
| 147 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.00015289 |
| 148 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99275225 |
| 149 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99149457 |
| 150 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98133674 |
| 151 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97737738 |
| 152 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.96914663 |
| 153 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.96914663 |
| 154 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.96914663 |
| 155 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96345480 |
| 156 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95806062 |
| 157 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95596992 |
| 158 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94928857 |
| 159 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.94726365 |
| 160 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.94610694 |
| 161 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.94058310 |
| 162 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93521979 |
| 163 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93376241 |
| 164 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93274038 |
| 165 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92407367 |
| 166 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92401092 |
| 167 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91065581 |
| 168 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90943660 |
| 169 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89017282 |
| 170 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88746487 |
| 171 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.88152188 |
| 172 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.88071495 |
| 173 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86694889 |
| 174 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86466659 |
| 175 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86208695 |
| 176 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83291715 |
| 177 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82739841 |
| 178 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82022337 |
| 179 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80369718 |
| 180 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78081374 |
| 181 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77966151 |
| 182 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77737544 |
| 183 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73940981 |
| 184 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73773179 |
| 185 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.73018485 |
| 186 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.72112624 |
| 187 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69042549 |
| 188 | GATA3_26560356_Chip-Seq_TH1_Human | 0.67785514 |
| 189 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67656386 |
| 190 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66969760 |
| 191 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65424967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 7.51932223 |
| 2 | MP0005409_darkened_coat_color | 6.19906492 |
| 3 | MP0004381_abnormal_hair_follicle | 5.85403278 |
| 4 | MP0009379_abnormal_foot_pigmentation | 4.92678517 |
| 5 | MP0001188_hyperpigmentation | 4.34905572 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.79691065 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.33414688 |
| 8 | MP0003436_decreased_susceptibility_to | 3.01491958 |
| 9 | MP0001800_abnormal_humoral_immune | 2.98593887 |
| 10 | MP0000920_abnormal_myelination | 2.87277006 |
| 11 | MP0003880_abnormal_central_pattern | 2.83598456 |
| 12 | MP0002009_preneoplasia | 2.82711696 |
| 13 | MP0005671_abnormal_response_to | 2.67950442 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.66408047 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.62192431 |
| 16 | MP0000685_abnormal_immune_system | 2.46707566 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.45951902 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.44435650 |
| 19 | MP0003724_increased_susceptibility_to | 2.42103682 |
| 20 | MP0005387_immune_system_phenotype | 2.42049170 |
| 21 | MP0001790_abnormal_immune_system | 2.42049170 |
| 22 | MP0002723_abnormal_immune_serum | 2.41870639 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.41772607 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.40452286 |
| 25 | MP0001819_abnormal_immune_cell | 2.36899936 |
| 26 | MP0000015_abnormal_ear_pigmentation | 2.35748653 |
| 27 | MP0005025_abnormal_response_to | 2.31729730 |
| 28 | MP0008057_abnormal_DNA_replication | 2.28064311 |
| 29 | MP0004742_abnormal_vestibular_system | 2.25577926 |
| 30 | MP0003828_pulmonary_edema | 2.16653289 |
| 31 | MP0002398_abnormal_bone_marrow | 2.08366522 |
| 32 | MP0009785_altered_susceptibility_to | 2.07910305 |
| 33 | MP0004142_abnormal_muscle_tone | 2.05779359 |
| 34 | MP0000566_synostosis | 2.03281966 |
| 35 | MP0002405_respiratory_system_inflammati | 1.96689478 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.92741423 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.92186427 |
| 38 | MP0000716_abnormal_immune_system | 1.91571119 |
| 39 | MP0005171_absent_coat_pigmentation | 1.87419890 |
| 40 | MP0002095_abnormal_skin_pigmentation | 1.83845350 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.83506820 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.82761331 |
| 43 | MP0000383_abnormal_hair_follicle | 1.79927452 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.75401374 |
| 45 | MP0005310_abnormal_salivary_gland | 1.74855547 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.74752688 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.74086508 |
| 48 | MP0004947_skin_inflammation | 1.73764307 |
| 49 | MP0006082_CNS_inflammation | 1.73435051 |
| 50 | MP0002722_abnormal_immune_system | 1.72875836 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.68073075 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.66428338 |
| 53 | MP0001346_abnormal_lacrimal_gland | 1.65839211 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.61318740 |
| 55 | MP0001486_abnormal_startle_reflex | 1.57724851 |
| 56 | MP0002006_tumorigenesis | 1.57357140 |
| 57 | MP0000613_abnormal_salivary_gland | 1.56889482 |
| 58 | MP0002429_abnormal_blood_cell | 1.50795120 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.49575507 |
| 60 | MP0000762_abnormal_tongue_morphology | 1.46581026 |
| 61 | MP0000579_abnormal_nail_morphology | 1.46180632 |
| 62 | MP0005451_abnormal_body_composition | 1.45102238 |
| 63 | MP0003011_delayed_dark_adaptation | 1.44902876 |
| 64 | MP0003938_abnormal_ear_development | 1.44626921 |
| 65 | MP0002102_abnormal_ear_morphology | 1.43322671 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.39245952 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.38532967 |
| 68 | MP0006292_abnormal_olfactory_placode | 1.30590716 |
| 69 | MP0000467_abnormal_esophagus_morphology | 1.30105277 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.26770190 |
| 71 | MP0001873_stomach_inflammation | 1.26726787 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.24827133 |
| 73 | MP0001299_abnormal_eye_distance/ | 1.22816800 |
| 74 | MP0010678_abnormal_skin_adnexa | 1.22311062 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 1.21711534 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.21711534 |
| 77 | MP0002751_abnormal_autonomic_nervous | 1.21321808 |
| 78 | MP0001905_abnormal_dopamine_level | 1.20863368 |
| 79 | * MP0004883_abnormal_blood_vessel | 1.20212530 |
| 80 | MP0003941_abnormal_skin_development | 1.18322579 |
| 81 | MP0002249_abnormal_larynx_morphology | 1.17108693 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 1.16997746 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.16853416 |
| 84 | MP0002132_abnormal_respiratory_system | 1.15857104 |
| 85 | MP0002272_abnormal_nervous_system | 1.15509528 |
| 86 | MP0009278_abnormal_bone_marrow | 1.15032775 |
| 87 | MP0002177_abnormal_outer_ear | 1.14071089 |
| 88 | MP0009046_muscle_twitch | 1.11491646 |
| 89 | MP0008260_abnormal_autophagy | 1.11013165 |
| 90 | MP0000778_abnormal_nervous_system | 1.10762636 |
| 91 | MP0001968_abnormal_touch/_nociception | 1.09072372 |
| 92 | MP0002734_abnormal_mechanical_nocicepti | 1.07506438 |
| 93 | MP0002998_abnormal_bone_remodeling | 1.06454197 |
| 94 | MP0003303_peritoneal_inflammation | 1.05973595 |
| 95 | MP0008469_abnormal_protein_level | 1.02688404 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 1.01117369 |
| 97 | MP0003045_fibrosis | 1.00031450 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.96624737 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.96351428 |
| 100 | MP0003632_abnormal_nervous_system | 0.95527579 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.93770982 |
| 102 | MP0000026_abnormal_inner_ear | 0.92530594 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.92054153 |
| 104 | MP0003787_abnormal_imprinting | 0.91810979 |
| 105 | * MP0001853_heart_inflammation | 0.90608424 |
| 106 | MP0001970_abnormal_pain_threshold | 0.88898897 |
| 107 | MP0005083_abnormal_biliary_tract | 0.88177544 |
| 108 | MP0002752_abnormal_somatic_nervous | 0.86912260 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.86560500 |
| 110 | MP0002229_neurodegeneration | 0.86069098 |
| 111 | MP0000371_diluted_coat_color | 0.85814326 |
| 112 | MP0003634_abnormal_glial_cell | 0.85527986 |
| 113 | MP0000049_abnormal_middle_ear | 0.84360265 |
| 114 | MP0003690_abnormal_glial_cell | 0.83493510 |
| 115 | MP0008004_abnormal_stomach_pH | 0.83347811 |
| 116 | MP0005408_hypopigmentation | 0.82421617 |
| 117 | * MP0000858_altered_metastatic_potential | 0.82327044 |
| 118 | * MP0001340_abnormal_eyelid_morphology | 0.81866310 |
| 119 | MP0000647_abnormal_sebaceous_gland | 0.80329270 |
| 120 | MP0002938_white_spotting | 0.79911012 |
| 121 | MP0001529_abnormal_vocalization | 0.79557591 |
| 122 | MP0002098_abnormal_vibrissa_morphology | 0.79203893 |
| 123 | MP0009745_abnormal_behavioral_response | 0.78941555 |
| 124 | MP0003866_abnormal_defecation | 0.78646565 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.76670562 |
| 126 | * MP0005164_abnormal_response_to | 0.75792114 |
| 127 | MP0005195_abnormal_posterior_eye | 0.74731990 |
| 128 | MP0002933_joint_inflammation | 0.74069630 |
| 129 | MP0002064_seizures | 0.73317542 |
| 130 | MP0001986_abnormal_taste_sensitivity | 0.73110822 |
| 131 | * MP0003091_abnormal_cell_migration | 0.72329722 |
| 132 | MP0005379_endocrine/exocrine_gland_phen | 0.72255293 |
| 133 | MP0005058_abnormal_lysosome_morphology | 0.72000433 |
| 134 | MP0003959_abnormal_lean_body | 0.70788814 |
| 135 | MP0000631_abnormal_neuroendocrine_gland | 0.70433653 |
| 136 | MP0000465_gastrointestinal_hemorrhage | 0.69526894 |
| 137 | MP0004885_abnormal_endolymph | 0.69149333 |
| 138 | MP0002876_abnormal_thyroid_physiology | 0.68847814 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.68701523 |
| 140 | MP0006276_abnormal_autonomic_nervous | 0.68460206 |
| 141 | * MP0002019_abnormal_tumor_incidence | 0.68406692 |
| 142 | MP0009115_abnormal_fat_cell | 0.67388335 |
| 143 | MP0001177_atelectasis | 0.65532282 |
| 144 | MP0005166_decreased_susceptibility_to | 0.65279842 |
| 145 | MP0008995_early_reproductive_senescence | 0.64424545 |
| 146 | MP0000377_abnormal_hair_follicle | 0.64245711 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.63594726 |
| 148 | MP0001502_abnormal_circadian_rhythm | 0.63340741 |
| 149 | * MP0000249_abnormal_blood_vessel | 0.63270052 |
| 150 | MP0002796_impaired_skin_barrier | 0.62928155 |
| 151 | MP0002282_abnormal_trachea_morphology | 0.62140232 |
| 152 | * MP0003448_altered_tumor_morphology | 0.61610480 |
| 153 | * MP0004484_altered_response_of | 0.61447121 |
| 154 | MP0002254_reproductive_system_inflammat | 0.61384559 |
| 155 | MP0006054_spinal_hemorrhage | 0.61167546 |
| 156 | MP0002882_abnormal_neuron_morphology | 0.60665346 |
| 157 | MP0001661_extended_life_span | 0.60595663 |
| 158 | * MP0009763_increased_sensitivity_to | 0.60130076 |
| 159 | MP0009250_abnormal_appendicular_skeleto | 0.60123104 |
| 160 | MP0002928_abnormal_bile_duct | 0.59437308 |
| 161 | MP0009764_decreased_sensitivity_to | 0.59399558 |
| 162 | MP0009765_abnormal_xenobiotic_induced | 0.59316569 |
| 163 | MP0004130_abnormal_muscle_cell | 0.58814041 |
| 164 | MP0010234_abnormal_vibrissa_follicle | 0.58658039 |
| 165 | MP0004270_analgesia | 0.57341253 |
| 166 | MP0001851_eye_inflammation | 0.56610576 |
| 167 | MP0006072_abnormal_retinal_apoptosis | 0.55597396 |
| 168 | MP0002735_abnormal_chemical_nociception | 0.55481505 |
| 169 | MP0005000_abnormal_immune_tolerance | 0.53648742 |
| 170 | MP0005388_respiratory_system_phenotype | 0.53071598 |
| 171 | MP0002133_abnormal_respiratory_system | 0.53071598 |
| 172 | MP0003937_abnormal_limbs/digits/tail_de | 0.52760776 |
| 173 | MP0005381_digestive/alimentary_phenotyp | 0.49453669 |
| 174 | MP0002419_abnormal_innate_immunity | 0.48038947 |
| 175 | MP0001216_abnormal_epidermal_layer | 0.47362416 |
| 176 | MP0002148_abnormal_hypersensitivity_rea | 0.47191818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal biliary tract physiology (HP:0012439) | 7.02044243 |
| 2 | Bile duct proliferation (HP:0001408) | 7.02044243 |
| 3 | Obstructive sleep apnea (HP:0002870) | 5.98951156 |
| 4 | Alacrima (HP:0000522) | 5.85082071 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.76877193 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.50443306 |
| 7 | Recurrent abscess formation (HP:0002722) | 5.08798989 |
| 8 | Decreased lacrimation (HP:0000633) | 4.88528826 |
| 9 | Parakeratosis (HP:0001036) | 4.84850665 |
| 10 | T lymphocytopenia (HP:0005403) | 4.50584753 |
| 11 | Myositis (HP:0100614) | 4.30257984 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.19405656 |
| 13 | Optic neuritis (HP:0100653) | 4.19405656 |
| 14 | Abnormality of T cell number (HP:0011839) | 4.17601057 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.15993365 |
| 16 | Orchitis (HP:0100796) | 4.02181488 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.85137176 |
| 18 | Recurrent skin infections (HP:0001581) | 3.85124172 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.84132411 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.80819408 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.79066761 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.73534305 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.68353523 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.68353523 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.64272404 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.63025863 |
| 27 | Sleep apnea (HP:0010535) | 3.55871842 |
| 28 | Recurrent viral infections (HP:0004429) | 3.46772909 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.40935657 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.35214134 |
| 31 | Gingivitis (HP:0000230) | 3.26191349 |
| 32 | Vasculitis (HP:0002633) | 3.21759385 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.19967006 |
| 34 | Peripheral hypomyelination (HP:0007182) | 3.17513481 |
| 35 | Abnormality of T cells (HP:0002843) | 3.09740541 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.04270684 |
| 37 | Colitis (HP:0002583) | 3.01006687 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.00938924 |
| 39 | Chest pain (HP:0100749) | 2.99618469 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.98741584 |
| 41 | Encephalitis (HP:0002383) | 2.96832024 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.96454154 |
| 43 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.92785859 |
| 44 | Split foot (HP:0001839) | 2.92542498 |
| 45 | Reduced antithrombin III activity (HP:0001976) | 2.91645113 |
| 46 | Gingival bleeding (HP:0000225) | 2.88848921 |
| 47 | Leukocytosis (HP:0001974) | 2.88450284 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.88233497 |
| 49 | Attenuation of retinal blood vessels (HP:0007843) | 2.86955686 |
| 50 | Pustule (HP:0200039) | 2.85880406 |
| 51 | Hemoptysis (HP:0002105) | 2.85813683 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.84575662 |
| 53 | Sensory axonal neuropathy (HP:0003390) | 2.81239242 |
| 54 | Increased IgE level (HP:0003212) | 2.79566086 |
| 55 | Subacute progressive viral hepatitis (HP:0006572) | 2.79492778 |
| 56 | Optic nerve hypoplasia (HP:0000609) | 2.78984062 |
| 57 | Optic disc pallor (HP:0000543) | 2.78702528 |
| 58 | Arterial thrombosis (HP:0004420) | 2.77690255 |
| 59 | Viral hepatitis (HP:0006562) | 2.76448939 |
| 60 | White forelock (HP:0002211) | 2.75964109 |
| 61 | Esotropia (HP:0000565) | 2.75526336 |
| 62 | Autoimmune hemolytic anemia (HP:0001890) | 2.69839705 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.68737023 |
| 64 | Septo-optic dysplasia (HP:0100842) | 2.68029759 |
| 65 | Cellulitis (HP:0100658) | 2.63191393 |
| 66 | Laryngomalacia (HP:0001601) | 2.60381582 |
| 67 | Urticaria (HP:0001025) | 2.59851129 |
| 68 | Epistaxis (HP:0000421) | 2.59455741 |
| 69 | Absent septum pellucidum (HP:0001331) | 2.58644819 |
| 70 | Absent speech (HP:0001344) | 2.54165965 |
| 71 | Patchy hypopigmentation of hair (HP:0011365) | 2.54164987 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.54145643 |
| 73 | Thyroid-stimulating hormone excess (HP:0002925) | 2.53254480 |
| 74 | Granulocytopenia (HP:0001913) | 2.50669311 |
| 75 | Hematochezia (HP:0002573) | 2.49584045 |
| 76 | * Abnormality of secondary sexual hair (HP:0009888) | 2.49027411 |
| 77 | * Abnormality of the axillary hair (HP:0100134) | 2.49027411 |
| 78 | Osteomyelitis (HP:0002754) | 2.48925279 |
| 79 | Eosinophilia (HP:0001880) | 2.48401407 |
| 80 | IgM deficiency (HP:0002850) | 2.45082233 |
| 81 | Pulmonary embolism (HP:0002204) | 2.44529304 |
| 82 | Type I transferrin isoform profile (HP:0003642) | 2.42429673 |
| 83 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.40017044 |
| 84 | Delayed myelination (HP:0012448) | 2.39511630 |
| 85 | Gangrene (HP:0100758) | 2.38350174 |
| 86 | Neurofibrillary tangles (HP:0002185) | 2.37574549 |
| 87 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.37216867 |
| 88 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.37216867 |
| 89 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.36957866 |
| 90 | Ocular albinism (HP:0001107) | 2.35742853 |
| 91 | Verrucae (HP:0200043) | 2.33847793 |
| 92 | Papilloma (HP:0012740) | 2.33847793 |
| 93 | Renal Fanconi syndrome (HP:0001994) | 2.32504918 |
| 94 | Abnormality of the septum pellucidum (HP:0007375) | 2.32336983 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.31146571 |
| 96 | Short tibia (HP:0005736) | 2.30972228 |
| 97 | Abnormality of the fingertips (HP:0001211) | 2.30594852 |
| 98 | Lymphopenia (HP:0001888) | 2.29968617 |
| 99 | Papilledema (HP:0001085) | 2.28696564 |
| 100 | Periodontitis (HP:0000704) | 2.27579439 |
| 101 | Ketosis (HP:0001946) | 2.27265816 |
| 102 | Abnormality of eosinophils (HP:0001879) | 2.25831462 |
| 103 | Chin dimple (HP:0010751) | 2.25106559 |
| 104 | Joint hemorrhage (HP:0005261) | 2.23378108 |
| 105 | Increased hepatocellular lipid droplets (HP:0006565) | 2.22929427 |
| 106 | Cupped ear (HP:0000378) | 2.21265153 |
| 107 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.20728902 |
| 108 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.19775203 |
| 109 | Atrophic scars (HP:0001075) | 2.19182352 |
| 110 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.19007025 |
| 111 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.14838001 |
| 112 | Abnormality of the peritoneum (HP:0002585) | 2.13769684 |
| 113 | Spastic paraparesis (HP:0002313) | 2.13313056 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12690413 |
| 115 | Abnormality of the pleura (HP:0002103) | 2.10791336 |
| 116 | Abnormality of magnesium homeostasis (HP:0004921) | 2.10789811 |
| 117 | Concave nail (HP:0001598) | 2.10224503 |
| 118 | Limited hip movement (HP:0008800) | 2.09833190 |
| 119 | Intrahepatic cholestasis (HP:0001406) | 2.08215814 |
| 120 | Stomach cancer (HP:0012126) | 2.07921646 |
| 121 | Hypoplasia of the thymus (HP:0000778) | 2.07532784 |
| 122 | Papillary thyroid carcinoma (HP:0002895) | 2.06567330 |
| 123 | Stomatitis (HP:0010280) | 2.06420148 |
| 124 | Sepsis (HP:0100806) | 2.05754259 |
| 125 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05301198 |
| 126 | Hypomagnesemia (HP:0002917) | 2.04873892 |
| 127 | Alveolar cell carcinoma (HP:0006519) | 2.03774118 |
| 128 | Anorexia (HP:0002039) | 2.02892398 |
| 129 | Episodic fever (HP:0001954) | 2.01566800 |
| 130 | Partial duplication of thumb phalanx (HP:0009944) | 2.01223814 |
| 131 | Meningitis (HP:0001287) | 2.01181242 |
| 132 | Short chin (HP:0000331) | 2.00720582 |
| 133 | Iris hypopigmentation (HP:0007730) | 2.00367648 |
| 134 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99670620 |
| 135 | Absent/shortened dynein arms (HP:0200106) | 1.99670620 |
| 136 | Obstructive lung disease (HP:0006536) | 1.99438756 |
| 137 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99438756 |
| 138 | Bifid scrotum (HP:0000048) | 1.97291914 |
| 139 | Hypertriglyceridemia (HP:0002155) | 1.97135647 |
| 140 | Fatigue (HP:0012378) | 1.96956961 |
| 141 | Amaurosis fugax (HP:0100576) | 1.96744104 |
| 142 | Lipid accumulation in hepatocytes (HP:0006561) | 1.94719812 |
| 143 | Conjunctival telangiectasia (HP:0000524) | 1.94578408 |
| 144 | Onion bulb formation (HP:0003383) | 1.94455866 |
| 145 | Abnormality of the prostate (HP:0008775) | 1.92748075 |
| 146 | Partial agenesis of the corpus callosum (HP:0001338) | 1.91476697 |
| 147 | Hypoplastic pelvis (HP:0008839) | 1.89889846 |
| 148 | Skin ulcer (HP:0200042) | 1.89338007 |
| 149 | Hypoplasia of the iris (HP:0007676) | 1.89300602 |
| 150 | Chronic diarrhea (HP:0002028) | 1.89144993 |
| 151 | Overfolded helix (HP:0000396) | 1.87869501 |
| 152 | Hypoplasia of the ulna (HP:0003022) | 1.87478896 |
| 153 | Asplenia (HP:0001746) | 1.87176142 |
| 154 | Severe combined immunodeficiency (HP:0004430) | 1.85758489 |
| 155 | Anomalous pulmonary venous return (HP:0010772) | 1.84659579 |
| 156 | Bradycardia (HP:0001662) | 1.84478397 |
| 157 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.84304463 |
| 158 | Peritonitis (HP:0002586) | 1.83126318 |
| 159 | Glomerulopathy (HP:0100820) | 1.82154715 |
| 160 | Thyroiditis (HP:0100646) | 1.82103101 |
| 161 | Abnormality of the pulmonary veins (HP:0011718) | 1.81372072 |
| 162 | IgG deficiency (HP:0004315) | 1.80855355 |
| 163 | Gastrointestinal stroma tumor (HP:0100723) | 1.80242558 |
| 164 | Thrombophlebitis (HP:0004418) | 1.79999602 |
| 165 | Prolonged neonatal jaundice (HP:0006579) | 1.79420857 |
| 166 | Renal agenesis (HP:0000104) | 1.78441058 |
| 167 | Hypochromic microcytic anemia (HP:0004840) | 1.78030290 |
| 168 | Morphological abnormality of the inner ear (HP:0011390) | 1.77991025 |
| 169 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77846639 |
| 170 | Micronodular cirrhosis (HP:0001413) | 1.77573442 |
| 171 | Macrocytic anemia (HP:0001972) | 1.77411394 |
| 172 | Annular pancreas (HP:0001734) | 1.77206307 |
| 173 | Amyloidosis (HP:0011034) | 1.76562537 |
| 174 | Generalized hypotonia (HP:0001290) | 1.76452434 |
| 175 | Partial duplication of the phalanx of hand (HP:0009999) | 1.74655180 |
| 176 | Abnormal ciliary motility (HP:0012262) | 1.73564025 |
| 177 | Polyneuropathy (HP:0001271) | 1.72904178 |
| 178 | Hypophosphatemic rickets (HP:0004912) | 1.71522526 |
| 179 | Acute hepatic failure (HP:0006554) | 1.71121918 |
| 180 | Flat occiput (HP:0005469) | 1.69906575 |
| 181 | Pruritus (HP:0000989) | 1.69363107 |
| 182 | Abnormality of B cell number (HP:0010975) | 1.69194297 |
| 183 | Slow saccadic eye movements (HP:0000514) | 1.68729502 |
| 184 | Esophageal atresia (HP:0002032) | 1.67278048 |
| 185 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.67015056 |
| 186 | Abnormally folded helix (HP:0008544) | 1.66601422 |
| 187 | Delayed CNS myelination (HP:0002188) | 1.64902721 |
| 188 | Congenital sensorineural hearing impairment (HP:0008527) | 1.64668654 |
| 189 | * Abnormal sex determination (HP:0012244) | 1.64380056 |
| 190 | * Sex reversal (HP:0012245) | 1.64380056 |
| 191 | Hepatosplenomegaly (HP:0001433) | 1.63621525 |
| 192 | Premature skin wrinkling (HP:0100678) | 1.63503614 |
| 193 | Microcytic anemia (HP:0001935) | 1.60024344 |
| 194 | Abnormality of the parathyroid morphology (HP:0011766) | 1.59434926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 9.77889501 |
| 2 | RIPK4 | 3.73345912 |
| 3 | MKNK2 | 3.64385530 |
| 4 | MAP4K1 | 3.11232490 |
| 5 | EIF2AK3 | 2.94007009 |
| 6 | TNIK | 2.93754404 |
| 7 | PHKG1 | 2.85372076 |
| 8 | PHKG2 | 2.85372076 |
| 9 | TYK2 | 2.60217458 |
| 10 | STK39 | 2.45281347 |
| 11 | GRK6 | 2.39160849 |
| 12 | MAP2K3 | 2.33083368 |
| 13 | TXK | 2.27751657 |
| 14 | CLK1 | 2.26327854 |
| 15 | MKNK1 | 2.19193046 |
| 16 | FES | 2.13488836 |
| 17 | BMPR2 | 2.02688723 |
| 18 | PKN1 | 1.99245253 |
| 19 | JAK3 | 1.96078586 |
| 20 | JAK1 | 1.83082347 |
| 21 | STK16 | 1.76687294 |
| 22 | ZAP70 | 1.75368367 |
| 23 | FGFR3 | 1.70511194 |
| 24 | BLK | 1.61059994 |
| 25 | TLK1 | 1.60412111 |
| 26 | EPHB1 | 1.53275763 |
| 27 | OXSR1 | 1.51174786 |
| 28 | MAP3K2 | 1.48968326 |
| 29 | EIF2AK2 | 1.47997031 |
| 30 | GRK1 | 1.47540739 |
| 31 | MAP3K3 | 1.47126990 |
| 32 | MAPK15 | 1.46260579 |
| 33 | SIK3 | 1.45371095 |
| 34 | PIK3CG | 1.44391445 |
| 35 | IRAK4 | 1.42808352 |
| 36 | MARK3 | 1.41735924 |
| 37 | UHMK1 | 1.40496228 |
| 38 | MAP3K10 | 1.37526488 |
| 39 | JAK2 | 1.33430938 |
| 40 | SGK2 | 1.26269627 |
| 41 | TNK2 | 1.19544723 |
| 42 | GRK7 | 1.16399641 |
| 43 | PBK | 1.15511960 |
| 44 | IKBKB | 1.09335637 |
| 45 | BMPR1B | 1.09333631 |
| 46 | SGK3 | 1.08010178 |
| 47 | CDK6 | 1.02078318 |
| 48 | STK10 | 1.00263266 |
| 49 | FGR | 0.99542017 |
| 50 | INSRR | 0.99250759 |
| 51 | CSNK1G1 | 0.97210194 |
| 52 | FRK | 0.95469285 |
| 53 | BRD4 | 0.94428712 |
| 54 | YES1 | 0.93742246 |
| 55 | NLK | 0.92433070 |
| 56 | MAPKAPK5 | 0.91089619 |
| 57 | IRAK2 | 0.89054160 |
| 58 | FGFR4 | 0.87915639 |
| 59 | TBK1 | 0.87529991 |
| 60 | PIM1 | 0.86278504 |
| 61 | MST4 | 0.85696706 |
| 62 | MATK | 0.84203316 |
| 63 | TGFBR2 | 0.83188702 |
| 64 | PAK2 | 0.81516577 |
| 65 | ADRBK2 | 0.80675192 |
| 66 | MELK | 0.79549173 |
| 67 | CSNK1G3 | 0.79431659 |
| 68 | MAPK7 | 0.78637080 |
| 69 | MUSK | 0.78174766 |
| 70 | CDK12 | 0.77096609 |
| 71 | KIT | 0.76614657 |
| 72 | TAOK1 | 0.75896400 |
| 73 | CAMK2B | 0.75779411 |
| 74 | VRK1 | 0.75667137 |
| 75 | ERBB4 | 0.75586238 |
| 76 | CSNK1A1L | 0.74145445 |
| 77 | DYRK2 | 0.73600746 |
| 78 | PNCK | 0.70675471 |
| 79 | PDK1 | 0.70533107 |
| 80 | CDK4 | 0.70427920 |
| 81 | IRAK1 | 0.70312151 |
| 82 | ROCK2 | 0.70214473 |
| 83 | TEC | 0.68821712 |
| 84 | TRPM7 | 0.67154741 |
| 85 | MAP3K6 | 0.66676862 |
| 86 | LRRK2 | 0.66553769 |
| 87 | TAOK3 | 0.65530906 |
| 88 | BCR | 0.64711814 |
| 89 | PRPF4B | 0.63242484 |
| 90 | WNK4 | 0.62145292 |
| 91 | CHUK | 0.61876306 |
| 92 | NEK6 | 0.60282478 |
| 93 | AKT3 | 0.60163518 |
| 94 | GSK3A | 0.59349686 |
| 95 | CDK19 | 0.58770703 |
| 96 | STK24 | 0.58680795 |
| 97 | MAPK13 | 0.58388159 |
| 98 | MAP2K2 | 0.58385194 |
| 99 | PRKAA2 | 0.58309047 |
| 100 | RET | 0.56908403 |
| 101 | STK4 | 0.55350014 |
| 102 | NEK9 | 0.55128671 |
| 103 | SGK223 | 0.55102270 |
| 104 | SGK494 | 0.55102270 |
| 105 | PRKG1 | 0.54297706 |
| 106 | CSK | 0.54140577 |
| 107 | DYRK1A | 0.53686334 |
| 108 | MAP3K14 | 0.53187028 |
| 109 | KSR2 | 0.51374330 |
| 110 | CDK3 | 0.50297351 |
| 111 | RAF1 | 0.50212983 |
| 112 | RPS6KA5 | 0.49754766 |
| 113 | FGFR2 | 0.49332940 |
| 114 | EGFR | 0.47386606 |
| 115 | CAMK2A | 0.47337156 |
| 116 | PDGFRB | 0.47047001 |
| 117 | * MAP3K1 | 0.46986066 |
| 118 | CSNK1G2 | 0.46911010 |
| 119 | LCK | 0.45020309 |
| 120 | ACVR1B | 0.44609857 |
| 121 | SRPK1 | 0.44587248 |
| 122 | MAP3K7 | 0.44439636 |
| 123 | MAP3K5 | 0.43687664 |
| 124 | CAMK2D | 0.42555794 |
| 125 | PRKCQ | 0.41013659 |
| 126 | PRKCE | 0.40872179 |
| 127 | ERBB2 | 0.40741317 |
| 128 | IRAK3 | 0.40545160 |
| 129 | DYRK1B | 0.40216404 |
| 130 | CAMKK1 | 0.39989214 |
| 131 | PTK2B | 0.39789189 |
| 132 | FER | 0.39279910 |
| 133 | CAMK2G | 0.38245944 |
| 134 | CAMK4 | 0.38112252 |
| 135 | HIPK2 | 0.37979572 |
| 136 | CSNK1D | 0.37117344 |
| 137 | WNK1 | 0.37089072 |
| 138 | LYN | 0.37050203 |
| 139 | MAPK4 | 0.37021974 |
| 140 | STK11 | 0.36101147 |
| 141 | PTK6 | 0.35863561 |
| 142 | MET | 0.35842190 |
| 143 | PRKD1 | 0.34907579 |
| 144 | ERN1 | 0.34412464 |
| 145 | MAPK12 | 0.34360443 |
| 146 | CAMKK2 | 0.33954916 |
| 147 | SGK1 | 0.32218743 |
| 148 | PDPK1 | 0.31112143 |
| 149 | ABL1 | 0.30845711 |
| 150 | IKBKE | 0.30566573 |
| 151 | MARK2 | 0.29812262 |
| 152 | NTRK2 | 0.27809391 |
| 153 | MST1R | 0.27291805 |
| 154 | ITK | 0.26988472 |
| 155 | MAPK11 | 0.26607860 |
| 156 | MAP3K13 | 0.26384430 |
| 157 | BTK | 0.26192580 |
| 158 | MAPK10 | 0.26178675 |
| 159 | SYK | 0.26143259 |
| 160 | * PAK1 | 0.25150590 |
| 161 | PRKACA | 0.24475324 |
| 162 | CSF1R | 0.23314192 |
| 163 | PRKCD | 0.23174951 |
| 164 | HCK | 0.21901141 |
| 165 | FYN | 0.21397879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.49445511 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.99893743 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.83820150 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.79582523 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72466637 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.68060724 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.59314180 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.54848068 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.53674425 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.50983952 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46997124 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.33607675 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.20092928 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.14727047 |
| 15 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 2.12364213 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03121361 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.92234911 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.89363709 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88916275 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86028853 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.81921041 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.80772909 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.80536794 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80368835 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.76942119 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70258043 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.69999205 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69913125 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69263857 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.69199244 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.65777077 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62611296 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59754203 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.56308563 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54693714 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54267789 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.49304424 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46515757 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45275693 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39059915 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.38744972 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38226308 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36900516 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.33701499 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33426005 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32691751 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.31597961 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29008442 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.28786956 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.27939988 |
| 51 | * Hepatitis B_Homo sapiens_hsa05161 | 1.27684468 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26417250 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24588632 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23261872 |
| 55 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23109685 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22979952 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22760354 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21051113 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20293964 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17617299 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16904359 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16172227 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15713528 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14656102 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12368271 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12138824 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10687094 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09623923 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.09237377 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.05749944 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04890771 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 1.03441866 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01539314 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01392025 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00405760 |
| 76 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00170586 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95947446 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.95669992 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95335272 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.94811582 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.94497699 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93410505 |
| 83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.91426189 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90112800 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89694009 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.87703636 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86914101 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86890899 |
| 89 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85798831 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85687516 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85220525 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.84915452 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83615347 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82350409 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80595561 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78318309 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77811356 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77035659 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76722905 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75432502 |
| 101 | Malaria_Homo sapiens_hsa05144 | 0.75210600 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75163012 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74558754 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.72782515 |
| 105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72483983 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72340571 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68710614 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68074328 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67752340 |
| 110 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.67674197 |
| 111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67147831 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66209952 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.64180946 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64152394 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62844226 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61873737 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61249862 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61149021 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60659125 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59754100 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.59426859 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58314464 |
| 123 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57389841 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.56875586 |
| 125 | Taste transduction_Homo sapiens_hsa04742 | 0.55904616 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55396791 |
| 127 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54389583 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54104481 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53503804 |
| 130 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52018181 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.51265014 |
| 132 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51262407 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51063774 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | 0.50115740 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50048528 |
| 136 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49978643 |
| 137 | Morphine addiction_Homo sapiens_hsa05032 | 0.49851872 |
| 138 | Allograft rejection_Homo sapiens_hsa05330 | 0.49388920 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49068398 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.49064070 |
| 141 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48139494 |
| 142 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47684096 |
| 143 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47377687 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46993693 |
| 145 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46689760 |
| 146 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46058113 |
| 147 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45753529 |
| 148 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45688180 |
| 149 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45650669 |
| 150 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45234981 |
| 151 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44481057 |
| 152 | Salmonella infection_Homo sapiens_hsa05132 | 0.43520174 |
| 153 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43171189 |
| 154 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42997646 |
| 155 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42938226 |
| 156 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42631482 |
| 157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42336445 |
| 158 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41598152 |
| 159 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38891744 |
| 160 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38150425 |
| 161 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38027293 |
| 162 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37364119 |
| 163 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.36479717 |
| 164 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35520816 |
| 165 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.34223308 |
| 166 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33968342 |
| 167 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30054613 |
| 168 | Homologous recombination_Homo sapiens_hsa03440 | 0.29804901 |
| 169 | Phagosome_Homo sapiens_hsa04145 | 0.29729518 |
| 170 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29548162 |
| 171 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29139458 |
| 172 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.27640104 |
| 173 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27328344 |
| 174 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26916490 |
| 175 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26777375 |
| 176 | Renin secretion_Homo sapiens_hsa04924 | 0.25837840 |
| 177 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24911577 |

